Coronavirus Disease 2019 (COVID‐19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Detalles Bibliográficos
Autores principales: Guo, Junyi, Huang, Zheng, Lin, Li, Lv, Jiagao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Viewpoints
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428639/
https://www.ncbi.nlm.nih.gov/pubmed/32233755
http://dx.doi.org/10.1161/JAHA.120.016219
_version_ 1783571120657530880
author Guo, Junyi
Huang, Zheng
Lin, Li
Lv, Jiagao
author_facet Guo, Junyi
Huang, Zheng
Lin, Li
Lv, Jiagao
author_sort Guo, Junyi
collection PubMed
description
format Online
Article
Text
id pubmed-7428639
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-74286392020-08-17 Coronavirus Disease 2019 (COVID‐19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Guo, Junyi Huang, Zheng Lin, Li Lv, Jiagao J Am Heart Assoc Viewpoints John Wiley and Sons Inc. 2020-04-01 /pmc/articles/PMC7428639/ /pubmed/32233755 http://dx.doi.org/10.1161/JAHA.120.016219 Text en © 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Viewpoints
Guo, Junyi
Huang, Zheng
Lin, Li
Lv, Jiagao
Coronavirus Disease 2019 (COVID‐19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
title Coronavirus Disease 2019 (COVID‐19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
title_full Coronavirus Disease 2019 (COVID‐19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
title_fullStr Coronavirus Disease 2019 (COVID‐19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
title_full_unstemmed Coronavirus Disease 2019 (COVID‐19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
title_short Coronavirus Disease 2019 (COVID‐19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
title_sort coronavirus disease 2019 (covid‐19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin‐converting enzyme inhibitors/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 infection
topic Viewpoints
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428639/
https://www.ncbi.nlm.nih.gov/pubmed/32233755
http://dx.doi.org/10.1161/JAHA.120.016219
work_keys_str_mv AT guojunyi coronavirusdisease2019covid19andcardiovasculardiseaseaviewpointonthepotentialinfluenceofangiotensinconvertingenzymeinhibitorsangiotensinreceptorblockersononsetandseverityofsevereacuterespiratorysyndromecoronavirus2infection
AT huangzheng coronavirusdisease2019covid19andcardiovasculardiseaseaviewpointonthepotentialinfluenceofangiotensinconvertingenzymeinhibitorsangiotensinreceptorblockersononsetandseverityofsevereacuterespiratorysyndromecoronavirus2infection
AT linli coronavirusdisease2019covid19andcardiovasculardiseaseaviewpointonthepotentialinfluenceofangiotensinconvertingenzymeinhibitorsangiotensinreceptorblockersononsetandseverityofsevereacuterespiratorysyndromecoronavirus2infection
AT lvjiagao coronavirusdisease2019covid19andcardiovasculardiseaseaviewpointonthepotentialinfluenceofangiotensinconvertingenzymeinhibitorsangiotensinreceptorblockersononsetandseverityofsevereacuterespiratorysyndromecoronavirus2infection

Ejemplares similares